Cancer Genetics – Flashcards

Unlock all answers in this set

Unlock answers
question
neoplasm
answer
tumor
question
tumor
answer
cell that has abnormal, uncontrolled growth -- benign and malignant
question
benign
answer
not invasive (not cancer)
question
malignant
answer
invades surrounding tissues and/or metastasize --> cancer
question
Metastasis
answer
spread of malignant tumor cells throughout the body (typically through the blood and lymphatic system)
question
carcinoma
answer
cancer arising from epithelial cells
question
sarcoma
answer
cancer arising from muscle cells
question
glioma
answer
cancer arising from cells of nervous system
question
leukemia and lymphoma
answer
cancer arising from from hematopoietic and lymphatic cells
question
Known causes of cancer
answer
Environmental (1-3)+genetics (4-5) 1. chemical exposure 2. radiation 3. infection 4. inherited genetic mutation 5. spontaneous sporadic mutations
question
Aflatoxin B
answer
Slide 10 - Environmental carcinogens - Can directly reacting with on DNA and induce mutations - Is a toxin from mold that grows on grain and peanuts when stored in humid tropical conditions; - A contributory cause of liver cancer in the tropics with a characteristic mutations in TP53.
question
Rous sarcoma virus (RSV)
answer
Slide 11 viral carcinogen (environmental)
question
Germline mutations
answer
Slide 12 - inherited from parents - present in eggs or sperms - cause *inherited cancer-predisposing syndromes* - account for 5% of all cancers
question
(Spontaneous) Somatic mutations
answer
- Are not heritable - Occur in specific tissues - Responsible for the majority, possibly all, types of cancers - Can occur during cell division
question
Cancer is a complex genetic disease that arises from malfunction of genes: *accumulation of genetic mutations/epigenetic changes.* T/F?
answer
Slide 14 T
question
What does accumulation of genetic mutations refer to in terms of cancer?
answer
Slide 15 - caused by a single mutated cell that undergoes a clonal evolution process - tumor progress with accumulation of mutations; single mutation is generally not enough to cause cancer (takes years)
question
What are the three types of cancer critical genes?
answer
1. Proto-oncogenes and oncogenes 2. Tumor-suppressor genes 3. DNA repair genes
question
Proto-Oncogenes vs oncogenes
answer
Slide 19 *Proto-oncogene:* genes which are involved in the promotion of cell division and proliferation, in which gain of function mutation can drive a cell toward cancer; *Oncogene*s: mutation, overactive or overexpressed forms of proto-oncogenes. *Gain of function; dominant at cellular level.*
question
Functions of Cellular Proto-Oncogenes
Functions of Cellular Proto-Oncogenes
answer
promote viability of cells through different methods e.g. RAS-GTPase, c-MYC, RET-Tyrosine kinase, MET-Tyrosine kinase, CD4-cell cycle, BCL2- Anti-apoptosis, BCR/ABL - Tyrosine kinase
question
Tumor Suppressor Genes
Tumor Suppressor Genes
answer
Slide 27 - Normally exerts a *negative effect* on cell division and proliferation. - *Recessive* at cellular level. - Loss of function in both alleles result in uncontrolled cell division and tumor formation - *'Loss of Heterozygosity' and 'Two Hit Hypothesis'*.
question
Example of loss of function of tumor suppressor gene that results in cancer
answer
RB1 gene, TP53 tumor-suppressor gene, DCC, WT1, BRCA1/2
question
Knudson Two Hit hypothes?s
answer
Inactivation of a tumor suppressor gene requires two mutations, inherited mutation and somatic mutation. LOH: Loss of Heterozygosity
question
The RB1 Gene
The RB1 Gene
answer
- Encodes Rb protein which is involved in cell cycle regulation; - mutations of Rb have also been identified in various cancers, including retinoblastoma, osteosarcomas, small-cell lung carcinomas, bladder, breast, pancreatic and prostate cancers.
question
Retinoblastoma (Rb)
answer
*Tumor of retinal stem cell* • Average age at presentation - unilateral 26 months - bilateral 8 months • Males and Females equally affected • Occurs in familial (~40%) and sporadic (~60%) forms • Familial more likely to be bilateral, younger • RB1gene on chr13 (first tumor suppressor gene discovered) • Knudson's Two Hit Hypothesis
question
TP53 tumor suppressor gene
answer
- In Chr. 17 and encodes a protein p53 with molecular weight 53 kDa. - 'Guardian of the genome': *Loss of function mutations in TP53 are the most common genetic changes observed in human cancer*, with mutations found in ; 50% of all tumors. - Germline mutations in TP53 cause the inherited cancer predisposing condition known as *'Li- Fraumeni syndrome'*, a rare *autosomal dominant* syndrome characterized by *neoplasms at multiple sites*, including breast cancer, soft tissue sarcomas, brain tumors, osteosarcoma, leukemia, and adrenocortical carcinoma.
question
The Adenomatous Polyposis Gene, APC
answer
an inhibitory component of the Wnt signaling pathway.
question
Familial Adenomatous Polyposis (FAP)
Familial Adenomatous Polyposis (FAP)
answer
*FAP* - also called *adenomatous polyposis coli (APC)* - *autosomal dominant* sub-type of colon cancer that is characterized by a large number of adenomatous polyps (;100). - caused by mutations in APC gene. - rare, less than 1% of total colon cancers *Somatic mutations in APC gene* - approximately 85% of all colon cancers Note: Colonoscopic removal of polyps could reduce the incidence of colon cancer by as much as 90%.
question
DNA Repair Genes
DNA Repair Genes
answer
- Genes that ensure each strand of genetic information is accurately copied during cell division of each cell cycle - Mutations in these genes lead to an increase in the frequency of mutations in other genes (such as tumor-suppressor gene and proto-oncogene)
question
BRCA 1 (Chr 17) / BRCA 2 (Chr 13)
answer
•BRCA1 is important for homologous recombination, cellular repair of DNA damage, and transcription of mRNA. •Mutations in BRCA1 also are involved in ovarian cancer. •BRCA2 plays a role in timing of mitosis in the cell cycle.
question
BRCA1/2 in Breast and Ovarian Cancer
answer
•Represents 31% of cancers in women •~5% of breast cancers are hereditary, with age of onset earlier than sporadic forms (mutations at 2 alleles). •Inherited breast/ovarian cancer is an *autosomal dominant* condition and occurs as a result of mutations in DNA repair genes: BRCA1 (Chr17) and/or BRCA2 (Chr13).
question
DNA *mismatch* repair genes
answer
mutations lead to Human Non-Polyposis Colon Cancer (HNPCC)
question
Human Non-Polyposis Colon Cancer (HNPCC)
answer
•2-3% of all colorectal cancer (CRC) cases. •*Autosomal dominant*, high penetrance. •Typical age of cancer onset is 40-50 years. •High lifetime risk of CRC and other cancers beginning age 20. •Caused by *mutations or deletions in mismatch repair (MMR) genes MSH2, MLH1, MSH6, (PMS2) , with 90% of detectable mutations in MSH2 and MLH1* •Tumor formation *requires mutation at the second allele*. •All four genes have homologsin yeast. •DNA blood tests are available for all four genes.
question
Prevention ; Diagnosis of cervical cancer
answer
Pap test ; HPV screening -- caused by Human Papilloma Virus Risk Factors: smoking, having many children, and human immunodeficiency virus (HIV) infection.
question
Genetic testing for heritable cancer
answer
- BRCA1/2 in breast and ovarian cancer -APC in familial adenomatous polyposis -Sets of cancer predisposing genes
question
Liver cancer prevention
answer
vaccine to hepatitis B; diet without cancer inducing chemicals
question
Detection of colon cancer
answer
colonoscopy
question
Prevention of lung cancer
answer
stay away from smoking tobacco
question
General cancer targeting strategies
answer
- All the clinically used cancer therapeutic reagents work by inhibiting oncogenic pathways. - Activating tumor suppressor genes is currently not feasible. - Several most common onco-drivers, such as K-Ras, MYC, are very difficult to target directly by anti-cancer drugs. - Targeting specific oncogenic mutation - Some anticancer drugs and drug targets in the RTK-Ras- MAP-kinase signaling pathway - Utility of tumor's genetic instability for therapy - synthetic lethality - Many Cancers Can Be Treatable by Enhancing the Immune Response Against the Specific Tumor - Treating patients simultaneously with several drugs has potential advantages
Get an explanation on any task
Get unstuck with the help of our AI assistant in seconds
New